Herzer, K; Sprinzl, M; Galle, PR
Hepatitis viruses: live and let dieLiver Int. Bd. 27. H. 3. 2007 S. 293-301
Wörns, MA; Weinmann, A; Galle, PR
Hereditäre LebererkrankungenGastroenterologie. Bd. 2. 2007 S. 135-153
Fantini, MC; Dominitzki, S; Rizzo, A et al.
In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells.Nat Protoc. Bd. 2. H. 7. 2007 S. 1789-1794
Weber, MM
-G. Stalla (Hrsg). Therapielexikon Endokrinologie und Stoffwechselkrankheiten. Springer-Verlag Berlin Heidelberg New York 2007
Gramont, A; Tournigand, C
Adjuvant therapy for stage II and III colorectal cancer.Semin Oncol. Bd. 34. H. Sup1. 2007 S. S37-40
Möhler, M; Galle, PR
Aktuelle Diagnostik und Therapie des MagenkarzinomsZ Gastroenterol. Bd. 2. H. 3. 2007 S. 17-32
Neufert, C; Becker, CH; Neurath, MF
An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression.Nat Protoc. Bd. 2. H. 8. 2007 S. 1998-2004
Hanefeld, M; Marx, N; Pfutzner, A et al.
Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.J Am Coll Cardiol. Bd. 49. H. 3. 2007 S. 290-7
Grifoni, D; Garoia, F; Bellosta, P et al.
aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia.Oncogene. Bd. 26. H. 40. 2007 S. 5960-5
Mudter, J; Neurath, MF
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.Gut. Bd. 56. H. 2. 2007 S. 293-303